PADUCAH, KY (August 27, 2024) - Mercy Health— Lourdes Hospital is thrilled to announce the Certificate of Need (CON) approval to move ahead with the construction of a state-of-the-art radiation cancer treatment facility and program. This significant milestone follows an extensive 13-year initiative that has endured meticulous approval processes and legal proceedings.
The new radiation facility complements the recent opening of Mercy Health— Lourdes Hospital's new Cancer Center, marking a crucial phase two in providing top-quality cancer treatments in the region. John J. Montville, Executive Director of the Oncology Service Line, expresses immense excitement regarding the full CON approval, stating, "This achievement is beyond exciting. Our dedication has brought us to this moment, and we remain steadfast in our commitment to guarantee our patients and their loved ones receive the most exceptional cancer care available. This heralds a new era for cancer treatment in Western Kentucky, and I am beyond pleased at this announcement."
With the Certificate of Need approval obtained, Mercy Health—Lourdes Hospital is now set to bring its plans to fruition. It will embark on an 18-month construction journey and establish a cutting-edge treatment and provider team. This will allow the many cancer patients treated at Mercy Health—Lourdes Hospital to get their comprehensive cancer care with the team they know and trust at a single Mercy Health location.
Mike Yungmann, President of Mercy Health, Kentucky, remarked, "The approval to advance with the construction of our new radiation facility and program is a pivotal moment that underscores our commitment to enhancing healthcare services in the region. This initiative represents a significant step forward in our mission to provide unparalleled care and signifies a substantial benefit to the Western Kentucky community. We look forward to this advancement's positive impact on our patients and the broader community as we continue to elevate healthcare standards and ensure accessible, high-quality cancer treatment for all."